SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2017 Uniondale, NY
Activity/Course #:
: 10.07.17PC
Cost:
: Free
Release/Start Date:
: Oct 07 2017
Expiration Date:
: Oct 07 2017
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.25 pharmacology hour(s)
Hardware/Software Requirements:

Saturday, October 7, 2017

Long Island Marriott Hotel & Conference Center
101 James Doolittle Boulevard
Uniondale, NY 11553
(516) 794-3800

Registration Fee
There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

Complimentary self-parking is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $189 per night at the Long Island Marriott Hotel & Conference Center. To reserve your room at this rate call (516) 794-3800 and ask for the NACE room block by September 26, 2017.  

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

At the conclusion of this program, participants should be able to:

1. List 2017 Quality Measures for the use of statin therapy for the prevention and treatment of cardiovascular disease; Explain the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction; Discuss ACC guidelines on the role of non-statin therapies in the management of atherosclerotic cardiovascular disease; Employ guideline-directed treatment strategies for primary and secondary prevention of cardiovascular disease in high-risk patient populations.

2. Recognize the evolving epidemiology and improvements in control rates of hypertension; Review proper blood pressure (BP) measurement technique and the role of office, home, and 24-hr Ambulatory BP measurement in the diagnosis and treatment of hypertension; Recognize current recommendations for first-line agents in the treatment of hypertension; Discuss the impact of recent trials and recommendations on evolving BP treatment goals for individualized therapy.

3. Describe the role of the kidney in glucose metabolism in health and disease; Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations; Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options; Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.

4. Describe strategies of care in COPD to improve diagnosis and ongoing symptom assessment; Tailor COPD pharmacotherapy according to current guidelines while incorporating unique patient needs and characteristics; Discuss the appropriate use of inhaled therapies for COPD, including the importance of proper inhaler technique; Collaborate with members of interprofessional health care team for effective chronic disease management.

5. Describe the role of persistent oncogenic HPV in the development of pre-cancer and cancer of the cervix; Describe the use of HPV testing as co-testing along with the Pap in cervical cancer screening for women 30 and older; Describe the use of HPV primary screening in women 25 and older; Describe 3 important messages that clinicians will teach women regarding HPV infection.

6. Discuss the diagnosis of osteoporosis and low bone mass; Discuss the role of non-pharmacologic agents in the prevention of bone fracture; Discuss the pharmacologic treatment of low bone mass and osteoporosis; Discuss the current controversies in management of osteoporosis.

 

Agenda*

7:30-8:00   Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Jack Kravitz, MD
8:10-9:20  

New Agents, New Options, and Expanded Potential In Lipid Management: Integrating The Data Into Practice
Jan Basile, MD

9:20-10:30  

Hypertension 2017: The Times and Guidelines Are Changing
Jan Basile, MD

10:30-10:50   Break
10:50-12:00   Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management: Evolving Treatment Strategies
Robert S. Busch, MD, FACE
12:00-1:00  

Lunch

1:00-2:10   The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes
Fernando J. Martinez, MD, MS
 2:10-3:20 

Cervical Cancer Screening: Appropriate Use of Pap & HPV Testing
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP

 3:20-3:30 Break
 3:30-4:40 Osteoporosis and Fracture Prevention Strategies
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
 4:40-4:45 

Program Summary and Closing Remarks
Jack Kravitz, MD

 *Agenda subject to change.

Faculty

Jan Basile, MD
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Division of General Internal Medicine
Medical University of South Carolina
Ralph H. Johnson VA Medical Center
Charleston, SC

Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
Adult Nurse Practitioner
Certified Menopause Practitioner
Millennium Affiliated Physicians
Division of Michigan Healthcare Professionals
Farmington Hills, MI

Robert S. Busch, MD, FACE
Director of Clinical Research
Albany Medical Faculty: Community Endocrine Group
Albany, NY

Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
Bruce Webster Professor of Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medical College
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, NY

Jack Kravitz, MD
Family Practice - Geriatrics
Coral Springs, FL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Cassandra A. McCullough, MBA
Chief Executive Officer
Association of Black Cardiologists
New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education (which includes 3.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Emerging Challenges in Primary Care: 2017 is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.; and an independent medical educational grant from Sunovion Pharmaceuticals, Inc.